Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cardiovascular & Hematological Disorders Drug Targets|November 3, 2011
Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological ConditionsEsma R Isenovic, Sanja Soskic, Hans-Dirk Dungen, et al.
Cardiovascular Drugs and Therapy|May 13, 2015
Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD TrialMilica Dekleva, Jelena Suzic Lazic, Ivan Soldatovic, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|July 12, 2017
Androgen status in non-diabetic elderly men with heart failureGoran Loncar, Biljana Bozic, Aleksandar N Neskovic, et al.
Biomarkers in Medicine|July 16, 2015
Should procalcitonin be measured routinely in acute decompensated heart failure?Goran Loncar, Verena Tscholl, Elvis Tahirovic, et al.
Heart Failure Reviews|June 7, 2021
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?Michele Correale, Renata Petroni, Stefano Coiro, et al.
Frontiers in Bioscience (Landmark Edition)|May 31, 2020
Soluble (pro)renin receptor in elderly chronic heart failure patientsDanilo Obradovic, Goran Loncar, Sara Radenovic, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 29, 2018
A new educational program in heart failure drug development: the Brescia international master programHans-Dirk Dungen, Renata Petroni, Michele Correale, et al.
ESC Heart Failure|March 16, 2023
Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF studyMichele Correale, Elena-Laura Antohi, Riccardo M Inciardi, et al.
Pageof 1